How drugmakers can succeed despite regional instability

In this week's Expert View, Cem Zorlular, chief executive of Turkish pharmaceutical company Er-Kim Pharmaceuticals, provides an insight into the commercialization of medicines amid challenging political circumstances.

Across the globe, tense relationships between countries are on the rise. The  PwC 25th Annual Global CEO Survey showed that 32% of executives cited geopolitical conflict as a top threat to growth, while 71% said it could inhibit their ability to deliver products or services.

These concerns are ongoing and set against a backdrop of the  International Monetary Fund’s April 2023 warning that the global economy is “entering a perilous phase.”